ARTV
ARTV
NASDAQ · Biotechnology

Artiva Biotherapeutics Inc

$4.01
+0.05 (+1.26%)
Day Range $3.91 — $4.04
52W Range $2.96 — $14.53
Open$4.00
Previous Close$3.96
Day High$4.04
Day Low$3.91
52W High$14.53
52W Low$2.96
Volume—
Avg Volume1.03M
Market Cap198.22M
P/E Ratio—
EPS$-3.43
SectorBiotechnology

Analyst Ratings

Strong Buy
12 analysts
11 Buy 1 Hold 0 Sell
Price Target +103.0% upside
Current
$4.01
Target
$8.14
$7.28 $8.14 avg $10.62

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 567.1K 1.13M 14.43M
Net Income -147,662,558 -265,527,077 -2,421,627
Profit Margin -26,045.0% -24,742.8% -16.8%
EBITDA -154,251,730 -292,785,501 -2,990,686
Free Cash Flow — — -1,604,262
Rev Growth -50.0% -50.0% +14.0%
Debt/Equity 0.00 0.00 0.31

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $469.15 +0.75% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $542.98 +0.81% 33.9 134.82B
REGN Regeneron Pharmaceuticals $959.96 +0.47% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $161.38 -2.22% 7.7 20.98B

Next Earnings

Nov 18, 2026
TBD
1 day away
EPS Est: $-0.56

ARTV News

No news for ARTV yet

Quick Stats

Market Cap198.22M
P/E Ratio—
EPS$-3.43
Volume—
SectorBiotechnology